Mental health & addiction

Progress on mental health and addiction is real — and often underreported. This archive covers treatment breakthroughs, policy shifts, community-led programs, and research advances that are improving lives. It’s evidence that change is possible.

Neurons inside human brain, for article on fentanyl relapse brain circuit

Brain circuit breakthrough paves way for opioid addiction treatments

Scientists have discovered a specific brain circuit that drives the emotional crash—anxiety, depression, craving—keeping people trapped in the fentanyl cycle even after they’ve stopped using. By identifying this discrete target, researchers now have a concrete mechanism to aim at rather than the broad-brush approach of current treatments. The finding matters because it fills a gap addiction medicine has long faced: understanding exactly how fentanyl rewires the brain. This precision opens a path toward tailored therapies that could ease withdrawal’s emotional weight and improve the odds of lasting recovery.\n\n**Word count: 99**

Abstract image with woman's face repeated, for article on psychedelics approved as medicines

Australia becomes world’s first country to officially recognize psychedelics as medicines

Psychedelic medicine just crossed a historic threshold — Australia is now the first country to give psychiatrists a legal pathway to prescribe psilocybin and MDMA as regulated treatments for PTSD and treatment-resistant depression. For patients who have cycled through every available option without relief, that’s a genuinely new door opening. The decision followed thousands of public submissions and a growing body of clinical evidence, including a landmark New Zealand Journal of Medicine study on psilocybin’s efficacy. It shows that political barriers — not just scientific ones — can eventually fall when evidence and public pressure align.\n\n—\n\n**Word count: 95**

Artwork of path into mind, for article on Colorado psychedelic decriminalization

Colorado voters pass historic psychedelic decriminalization act

Colorado’s Natural Medicine Health Act goes further than any previous U.S. state psychedelic law, removing criminal penalties for personal use of psilocybin, DMT, ibogaine, and mescaline — and building a licensed therapy clinic system alongside it. The FDA has already granted psilocybin “breakthrough therapy” status for treatment-resistant depression, giving this reform unusual clinical credibility. Colorado helped pioneer cannabis legalization in 2012, and advocates are watching to see whether psychedelic reform follows a similar path outward. For people who haven’t found relief through conventional treatments, this law opens a genuinely new door.

Cannabis being weighed, for article on legal cannabis dispensary, for article on Germany cannabis legalization

Germany to become second E.U. nation to legalize recreational cannabis

Recreational cannabis legalization in Germany would mark a significant shift for Europe’s largest economy — moving the country away from a prohibition model that its own health minister says has shown no clear results. The proposal would allow licensed shops and pharmacies to sell cannabis to adults, with age-based limits on potency designed to protect younger users. Because Germany sits at the heart of the E.U., its approach could reshape how other member states think about drug policy far more than smaller precedents have. This is what evidence-based reform looks like in practice.